Charlotte's Web CBD Flower
Charlotte's Web Indoor Flower
Mind CBD Sachets
Charlotte's Web CBD Flower Analysis

Charlotte (Indoor) - CBD 19.3%

Charlotte of Swiss origin, grown indoors and hand-harvested, with a CBD content of 19.3%. Its colour ranges from light green to deeper shades, and its aromas of citrus, pine and sweet notes make it a highly aromatic hybrid.
Regular price 13,80 € Sale price instead of 24,00 €

Availability: In stock – Ships within 24h

6,90 €/g
Tax included. Shipping calculated at checkout.
En Stock !
Livré en France sous 2 à 3 jours
Vous n'êtes pas en France ?

Summary

Charlotte CBD Flower Grown indoors in Switzerland (Indoor)

  • Flavours: Citrus, Pine, Sweet
  • CBD 19.3%
  • Sativa-dominant hybrid
  • Hand-harvested

See all products:

Details

Charlotte Indoor CBD Flower

Here is a 100% natural flower of Swiss origin with a beautiful colour ranging from light green to olive green.

This flower has citrus scents deliciously blended with sweet, woody and peppery notes. It is very well endowed with CBD, at a level of 19.3%.

Superb aroma, very firm and compact buds, particularly careful trimming.

Cultivation method
Organic cultivation indoors in Switzerland (Indoor).

Species
Sativa-dominant hybrid.

Concentration

  • CBD: 19.33%
  • THC: 0.29%

Certification
Charlotte CBD flowers grown in Switzerland, then certified by an independent, GMP-approved European laboratory.

Legislation
100% legal product in the European Union. This variety is a hybrid derived from varieties authorised in the European catalogue.

*Non-contractual photos, taken by us from the batch currently on sale*

Flavours

Charlotte Indoor CBD Flower 19.3%

  • Citrus
  • Pine
  • Sweet

Similar products

Discover other Indoor CBD flowers:

Sources and references (4)

Official and scientific sources on the regulation, safety, composition and quality of this type of product. They are provided for information and are not health claims.

  1. MILDECA (2021). L'indispensable sur... le cannabidiol (CBD). MILDECA — drogues.gouv.fr. View the source
  2. MILDECA (2023). Le CBD. drogues.gouv.fr (Mission interministérielle de lutte contre les drogues et les conduites addictives). View the source
  3. Chevallier C, Charuel L, Richeval C, Chaouachi L, Del Valle L, Eiden C, Gaulier JM, Batisse A (CEIP-A Paris, Lyon, Montpellier ; CHU Lille) (2023). Cannabidiol : analyse de produits « CBD non pharmaceutiques » disponibles sur le marché en France. MILDECA — drogues.gouv.fr (rapport CEIP-A financé par la MILDECA). View the source
  4. Dryburgh LM, Bolan NS, Grof CPL, et al. (2018). Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology. View the source

Recently viewed